These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8669812)

  • 1. Human monoclonal antibody developed against a metastasizing paraganglioma: preparation and preclinical studies.
    Freiberg B; Puhlmann CM; Anderer FA
    Anticancer Res; 1995; 15(6B):2489-93. PubMed ID: 8669812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor effects of murine monoclonal antibody NCC-ST-421 reacting with dimeric Le(a) (Le(a)/Le(a)) epitope.
    Watanabe M; Ohishi T; Kuzuoka M; Nudelman ED; Stroud MR; Kubota T; Kodairo S; Abe O; Hirohashi S; Shimosato Y
    Cancer Res; 1991 Apr; 51(8):2199-204. PubMed ID: 1706961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
    Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
    Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of anti-human retinoblastoma monoclonal antibody by solid tumor cell immunization and study on characteristics of its antigen].
    Zhong X; Li Y; Ning B; Yan J; Li Y; Luo G; Lin J; Ying F; Feng G
    Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):691-4. PubMed ID: 12487903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
    Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 10. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
    De Santis R; Albertoni C; Petronzelli F; Campo S; D'Alessio V; Rosi A; Anastasi AM; Lindstedt R; Caroni N; Arseni B; Chiodi P; Verdoliva A; Cassani G; Chinol M; Paganelli G; Carminati P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2191-6. PubMed ID: 16609034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization.
    Popkov M; Sidrac-Ghali S; Alakhov V; Mandeville R
    Clin Cancer Res; 2000 Sep; 6(9):3629-35. PubMed ID: 10999755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies.
    Kan-Mitchell J; Mitchell MS
    Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
    Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
    Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against human malignant melanoma.
    Sorg C; Brüggen J; Suter L; Bröcker EB
    Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies.
    Hixson DC; Brown J; McBride AC; Affigne S
    Exp Mol Pathol; 2000 Jun; 68(3):152-69. PubMed ID: 10816384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generation and characterization of monoclonal antibody GCF-5 to human giant cell tumor of bone].
    Zhou L
    Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):79-81. PubMed ID: 8223010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.